Oral Transmucosal Drugs Market

Oral Transmucosal Drugs Market Research, 2032

The Global Oral Transmucosal Drugs Market was valued at 28.65 billion USD in 2021 and is expected to reach 58.2 billion USD by 2032, increasing at a CAGR of 6.7% during the forecast period, ie, 2022-2032

Oral transmucosal delivery means systemic administration of medication via the mucous membrane of the oral cavity. The transmucosal drug delivery system has various benefits making it profitable market. Transmucosal drug delivery allows drugs to bypass the body's natural defense mechanisms and are available in dosage forms like tablets, gels, thin films and they dissolve in the mouth. Oral transmucosal drugs can bypass hepatic first-pass metabolism and avoid degradation of drugs in the gastrointestinal tract.

Market Highlights

Global Oral Transmucosal Drugs Market is expected to project a CAGR of 6.7%

The Global Oral Transmucosal Drugs Market was valued at 28.65 billion USD in 2021 and is expected to reach 58.2 USD billion by 2032, increasing at a CAGR of 6.7% during the forecast period, ie, 2022-2032 owing to increasing incidence of respiratory problems, autoimmune disorders, cancer, mucositis etc. The people getting affected by autoimmune disorders, respiratory problems, oral cancer, etc. are increasing leading to rise of the market across the world. This increases the requirement of oral transmucosal drugs to prevent gastrointestinal degradation and provide rapid onset of action. The number of patients with chronic diseases is rising across the world which increases the pre-surgical procedures which is expected to increase the global oral transmucosal drugs market.

Global Oral Transmucosal Drugs Market : Segments

Tablets segment is expected to grow with a higher CAGR during 2022-32

Global Oral Transmucosal Drugs Market is classified based on the Product Type into Tablets, Films, Liquid & Spray, and Others. The Tablet segment is expected to witness growth over the forecast period. Oral transmucosal tablets dissolve in the mouth easily with little residue and they absorb quickly which is important in emergencies like heart attacks. The advantages of oral transmucosal tablets like predictable potency, ease of administration, and reduced side effects with other medications.

Online pharmacy segment is expected to grow with a higher CAGR during 2022-32

Global Oral Transmucosal Drugs Market is classified based on the Distribution Channel into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies. The retail pharmacy segment dominated the market in terms of revenue in 2021 owing to the factors like high availability of all the drug products related to the Oral Transmucosal delivery through the retail channels. The increasing inheritance of online pharmacy and ordering through mail are further expected to drive the growth Global Oral Transmucosal Drugs market.

Market Dynamics                                            

Growth Drivers

Incidence of chronic diseases may boost the market growth

There is a rise in the prevalence rate of chronic diseases which may assist in the growth of the Global Oral Transmucosal Drugs Market. Due to the uneven eating habits and the consumption of food at irregular timings may lead to the occurrence of gastric issues, and the growth of gastrointestinal diseases might propel the market growth of the oral transmucosal drug market.   

Rising R&D activities may drive the market growth

An increase in the prevalence of diseases is leading to the rise in research and development activities to invent new drugs with improved activities which is resulted in the growth of product launches pertaining to a disease and it is expected to boost the market growth over the forecast period. An increase in burden of diseases like Parkinson's, migraine and the rising geriatric population with diseases may require the oral drugs which may propel the growth of the oral transmucosal drugs market over the forecast period.

Restraint

High Cost may restrain the market growth

The high cost of drug production may obstruct the market growth. There are few disadvantages of drug delivery by oral route like smaller surface area, low permeability when compared with sublingual membrane which may hamper the market growth. The regulatory changes in guidelines for combination products are changed regularly and which may restrain the market growth in the forecast period.

Recent Developments

• ??In September 2021, IntelGenx Corp. launched RIZAPORT with a partner as Exeltis Healthcare SL in the European Union for RIZAPORT. It is an oral film formulation of rizatriptan benzoate.
• In January 2021, CURE Pharmaceutical's oral soluble film containing sildenafil citrate (the active ingredient in Viagra) product, CURE film Blue, used to treat erectile dysfunction, received FDA approval for an Investigational New Drug application (INDA).

Key Players:

• ZIM Laboratories Limited

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

• Aquestive Therapeutics, Inc.
• IntelGenx Corp.
• CLPHarm Co., Ltd.
• Novartis AG
• Seoul Pharmaceuticals
• Pfizer Inc.
• Shilpa Therapeutics
• Teva Pharmaceutical Industries Ltd.
• Sunovion Pharmaceuticals, Inc.
• Other Prominent Players

Global Oral Transmucosal Drugs Market : Regions

Global Oral Transmucosal Drugs Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. Based on regional analysis, North America holds the largest market share of oral transmucosal drugs market and is also expected to dominate the market in the forecast period owing to the high prevalence of diseases which require the administration of oral medications in people such as Alzheimer's, PD, dental disorders, dysphagia and in the geriatric people. The rise in the number of dental visits in the country is also expected to drive the demand for oral transmucosal drugs.

Global Oral Transmucosal Drugs Market is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities, YoY Growth, CAGR – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, YoY Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, YoY Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, YoY Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, YoY Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Global Oral Transmucosal Drugs Market report also contains analysis on:

Global Oral Transmucosal Drugs Market Segments:

• By Product Type
  • Tablets
  • Films
  • Liquid & Spray
  • Others
• By Route of Administration
  • Sublingual Mucosa
  • Buccal Mucosa
  • Others
• By Indication
  • Opioid Dependence
  • Nausea and Vomiting
  • Erectile Dysfunction
  • Neurological Disorders
  • Others
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies  
• Global Oral Transmucosal Drugs Market Dynamics
• Global Oral Transmucosal Drugs Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restrictions

Global Oral Transmucosal Drugs Market Report Scope and Segmentation

Frequently Asked Questions (FAQ):